CAS NO: | 197509-46-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Laniquidar (R101933) is a noncompetitive, third generationP-glycoprotein(P-gp)inhibitor with anIC50of 0.51 μM. Laniquidar can be used for modulating multidrug resistance transporters[1]. Laniquidar can also be used for studying acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)[2]. Laniquidar has limited oral bioavailability[3]. |
IC50& Target | IC50: 0.51 μM (P-glycoprotein)[1] |
Clinical Trial | |
分子量 | 584.71 |
Formula | C37H36N4O3 |
CAS 号 | 197509-46-9 |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |